Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Dr Reddy’s Laboratories ( (RDY) ) has provided an announcement.
On July 2, 2025, Dr. Reddy’s Laboratories announced the publication of a newspaper advertisement regarding the notice of its 41st Annual General Meeting and e-voting information. This announcement, made in compliance with Regulation 47 of the Securities and Exchange Board of India, was published in the Business Standard and Nava Telangana newspapers. The move underscores the company’s commitment to transparency and regulatory compliance, ensuring stakeholders are informed about important corporate governance events.
The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
Dr Reddy’s Laboratories’ strong financial performance is the most significant factor, underscored by consistent revenue growth and profitability. Technical analysis supports a favorable stock trend, although valuation is fair with modest income potential. The absence of earnings call and corporate events data did not impact the overall score.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a global pharmaceutical company based in Hyderabad, India. It is engaged in the manufacturing and marketing of a wide range of pharmaceuticals, including generic medications, active pharmaceutical ingredients (APIs), and proprietary products. The company focuses on providing affordable and innovative medicines to patients worldwide.
Average Trading Volume: 2,008,586
Technical Sentiment Signal: Strong Buy
Current Market Cap: $12.44B
Find detailed analytics on RDY stock on TipRanks’ Stock Analysis page.